Xilio Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Xilio Therapeutics

04/08/2025 12:50

Xilio Therapeutics Inc XLO.OQ XLO.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

The Waltham Massachusetts-based  company is expected to report a 214.0% increase in revenue to $7.4 million from $2.36 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Xilio Therapeutics Inc is for a loss of 10 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated August 4 at 11:50 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)